SARMs Legal Status and Safety: What the Evidence Says

Is MK-677 a SARM? Is It a Steroid?

No on both questions. MK-677, also called ibutamoren, is a growth hormone secretagogue: it works by prompting the body to release more of its own growth hormone through the ghrelin receptor. The US NIH LiverTox database describes ibutamoren directly as a non-peptide agonist of the ghrelin receptor and a growth hormone secretagogue, and notes that it is sometimes mistakenly claimed to be a SARM. It is not a steroid either. Steroids and SARMs both act on the androgen receptor; MK-677 does not touch that receptor at all, so filing it under either label gets the mechanism wrong from the start.

The label matters here, because it decides which rules apply. In competitive sport, MK-677 is banned, but the World Anti-Doping Agency places it in a different section of the Prohibited List from the SARMs: ibutamoren sits under S2, growth hormone secretagogues and their releasing factors, while SARMs sit under the separate S1.2 anabolic agents category. Searches like is mk677 a sarm and is mk-677 a steroid or sarm both have the same answer: neither, and the receptor it acts on is the reason why. For the full mechanism, what research describes about its effects, and the legal picture in more depth, see the MK-677 guide.

Is Ibutamoren (MK-677) Legal?

Legal is the wrong frame here, because ibutamoren has never been approved by any drug regulator as a medicine for people. It is sold as a research chemical rather than a licensed product, which means that in most places it is not legal to sell as a supplement or a drug for human use, even where simple possession is not directly criminalized. The US FDA's position on the wider category is blunt: products marketed for bodybuilding that contain compounds like this are unapproved drugs the agency has not reviewed for safety and effectiveness, whatever the label says.

In Vietnam specifically, this page is not going to print a legal classification that has not been verified, because it is not something a guide can pin down reliably and the rules shift. What is documented: Vietnam registers medicines through the Drug Administration of Vietnam (Cuc Quan ly Duoc), under the Ministry of Health, and a compound that is not an approved medicine anywhere does not carry a normal medicine registration there either. Unapproved drugs and research chemicals are subject to import controls rather than a supplement pathway. If you need to understand your own exposure, that is a question for a qualified local professional, not a seller with a stake in the answer. The SARMs guide covers the same legal shape across the whole category.

Is Cardarine (GW-501516) a SARM? What Is the Cancer Study?

Cardarine is not a SARM. GW-501516, the compound sold under the name cardarine, is a PPAR-delta agonist, a different mechanism entirely: it acts on a metabolic receptor involved in how the body handles fat and energy, not the androgen receptor that SARMs and steroids use. The US NIH LiverTox database identifies cardarine as a peroxisome proliferator-activated receptor delta (PPAR-delta) agonist and lists it separately from the SARMs entry. WADA draws the same line: cardarine sits among the metabolic modulators on the Prohibited List, not among the S1.2 anabolic agents where SARMs live. So the search gw501516 not a sarm ppar delta agonist source has a clean answer, and this is the source for it.

The cancer question is the actual reason cardarine never became a marketed drug. GlaxoSmithKline developed GW-501516 for lipid and metabolic disease, then halted the program after long-term animal studies found cancer. A peer-reviewed letter in Pulmonary Circulation states it plainly: "GW501516 causes cancer in rats and mice after 104 weeks of dosing," a finding that led the World Anti-Doping Agency and Health Canada to issue warnings and led Australia to classify the compound as a poisonous substance in April 2018 (Mitchell and Bishop-Bailey, Pulmonary Circulation, 2018, PMID 30351241).

The underlying carcinogenicity data came from GlaxoSmithKline abstracts presented at the 2009 Society of Toxicology meeting, and the same peer-reviewed letter notes plainly that those two studies were never published as full papers, only as conference abstracts. That is not a reason to wave the finding away: it is a real signal, from the company's own long-term dosing studies, serious enough that it ended clinical development and triggered regulator warnings. It is also not a peer-reviewed human trial, and it was run in rodents at research doses over a 104-week study, not in people. The cancer signal is real, and it is why cardarine was dropped. At the same time, the primary data behind it still sits in conference abstracts, not a published paper. Anyone telling you cardarine is proven safe in humans, or that the cancer finding is fake or overblown, is misstating the record in one direction or the other. Cardarine's endurance and fat-loss marketing claims are studied rather than proven in humans, full stop. The complete write-up, including what is and is not known about human use, is at the cardarine guide.

Is Ostarine Legal? Is Ostarine a Steroid?

Ostarine is not a steroid, and it is not an approved medicine, which is why legal is the wrong frame here too. Ostarine, also called enobosarm or MK-2866, is a genuine SARM: it acts on the androgen receptor with some tissue selectivity, which is the actual definition of the category. The US NIH LiverTox database lists enobosarm (ostarine, MK-2866) among the SARMs and states plainly that none of the agents was approved for human use. It is not a steroid, because steroids are a distinct chemical class, though both act on the same receptor family, which is exactly why people confuse the two.

Ostarine has never been approved by any drug regulator for people, so it circulates as a research chemical. The US FDA has sent warning letters to companies selling ostarine in products marketed as supplements, on the grounds that those products are unapproved drugs. LiverTox also documents that SARMs, ostarine included, have caused severe cholestatic jaundice resembling anabolic-steroid liver injury, with cases showing up months after use began. In Vietnam, as with the others on this page, this guide is not going to assert a specific legal classification it cannot verify. The reliable move is to treat ostarine as an unapproved compound and confirm your own position with a qualified professional rather than a supplier. The full profile, including what the early human trials do and do not show, is at the ostarine guide.

Does LGD-4033 or Ostarine Cause Cancer?

There is no published human study showing that LGD-4033 or ostarine causes cancer, and saying otherwise would be dishonest, so this page is not going to say it. The strong animal cancer finding people are half-remembering belongs to cardarine (GW-501516), a PPAR-delta agonist covered above, not to the SARMs, and mixing the two up is exactly what drives searches like lgd 4033 cause cancer. What research does document for the SARMs is a different risk: liver injury. LGD-4033 (ligandrol) is named in the US NIH LiverTox database among the SARMs linked to cholestatic liver injury, and a published case report ties drug-induced liver injury to LGD-4033 use in an otherwise healthy adult.

The cancer question and the SARMs get conflated because cardarine is often sold through the same channels and discussed in the same threads. But the animal cancer data belongs to cardarine specifically, and what is documented for LGD-4033 and ostarine is liver toxicity, plus the hormone-suppression and cardiovascular concerns the FDA lists for the category as a whole. None of these compounds have clean long-term human safety data, because none were carried through the full approval process that would produce it, and the absence of a cancer study is not the same thing as a clean bill of health. The LGD-4033 guide has the compound-specific detail.

SARMs Legal Status: Are They Banned in Sport, and Controlled?

Yes to both, in different ways. SARMs are banned in sport at all times, and the whole category also sits outside normal medicine regulation everywhere. The World Anti-Doping Agency prohibits SARMs under section S1.2, other anabolic agents, and USADA states plainly that all SARMs are prohibited at all times, both in and out of competition, for all athletes, and that all SARMs are for investigational purposes only, meaning they are not approved by the FDA for human use. The list names ostarine (enobosarm), andarine, LGD-4033 (ligandrol), and RAD-140 among others.

Outside sport, controlled means different things in different countries, so there is no single global answer to give. In the United States, SARMs are not approved drugs, the FDA treats products containing them as illegal unapproved drugs, and separate legislation has moved to schedule several of them by name. Elsewhere the picture varies: some countries treat them as prescription-only or restricted substances, others sit in a genuine grey area. Vietnam regulates medicines through the Drug Administration of Vietnam and applies import controls to unapproved drugs, so a research chemical that is not a registered medicine does not clear the same path a licensed drug does. If the real question behind your search is your own legal exposure in a specific place, that is a question for a lawyer or a licensed pharmacist there, not for this page and not for whoever is selling the compound. For how these compounds compare to steroids and to peptides more broadly, see SARMs vs Steroids and SARMs vs Peptides, and the RAD-140 profile has the compound-specific detail.

Regulatory and Safety Status at a Glance

Here is the legal and safety picture for the five compounds people ask about most, sourced and non-dosing. This is not a purchase guide, and nothing in this table is a recommendation to use or avoid anything.

Sources for every cell above are named in full in the References section below, with links to the original FDA, WADA, USADA, LiverTox, and Pulmonary Circulation pages.

Frequently Asked Questions

References